OROPHARYNX CANCER, STAGE III

Clinical trials for OROPHARYNX CANCER, STAGE III explained in plain language.

Never miss a new study

Get alerted when new OROPHARYNX CANCER, STAGE III trials appear

Sign up with your email to follow new studies for OROPHARYNX CANCER, STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for throat cancer: testing a powerful immune drug against standard treatment

Disease control Ongoing

This study is testing whether a newer immunotherapy drug (pembrolizumab) combined with radiation works better than the current standard treatment of chemotherapy plus radiation for people with advanced head and neck cancer. It will involve 126 patients whose cancer is linked to t…

Matched conditions: OROPHARYNX CANCER, STAGE III

Phase: PHASE2 • Sponsor: Loren Mell, MD • Aim: Disease control

Last updated Mar 30, 2026 14:35 UTC

OROPHARYNX CANCER, STAGE III

Get alerted when new OROPHARYNX CANCER, STAGE III trials appear

New hope for throat cancer: testing a powerful immune drug against standard treatment